Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Test – Advanced Cardiovascular Risk Assessment with Serum-Based Photometry Analysis
1.250,00 د.إSample Type : Serum
Methodology : Photometry
TAT : 15 Days
Showing 625–640 of 970 results
Sample Type : Serum
Methodology : Photometry
TAT : 15 Days
Sample Type : Serum
Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology
TAT : 8-10 Days
Sample Type : ThinPath™ LBC
Methodology : Liquid-Based Cytology by SurePath™ & PCR
TAT : 3 days
Sample Type : Serum
Methodology : Spectrophotometry
TAT : 10 Days
Sample Type : Fixed Tissue in 10% Formalin
Methodology : Histopathology
TAT : 4 days
Sample Type : Serum
Methodology : Immunoblot
TAT : 10 Days
Sample Type : Serum
Methodology : Spectrophotometry
TAT : 1 Day
Sample Type : Serum
Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology
TAT : 8-10 Days
Sample Type : Serum
Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology
TAT : 8-10 Days
Sample Type : Whole Blood
Methodology : Atomic absorption
TAT : 10 Days
Sample Type : Serum
Methodology : Spectrophotometry
TAT : 1 Day
Includes the following parameters: